Browse > Article

Mutant Presenilin 2 Increases Acetylcholinesterase Activity in Neuronal Cells  

Nguyen Hong Nga (College of Pharmacy, Chungbuk National University)
Hwang Dae Youn (National Institute of Toxicological Research, Korea Food and Drug Administration)
Kim Young Kyu (National Institute of Toxicological Research, Korea Food and Drug Administration)
Yoon Do Young (Lab of Cell Biology, Korea Research Institute of Bioscience and Biotechnology)
Kim Jae Hwa (Lab of Cell Biology, Korea Research Institute of Bioscience and Biotechnology)
Lee Moon Soon (National Institute of Environmental Research)
Lee Myung Koo (College of Pharmacy, Chungbuk National University)
Yun Yeo Pyo (College of Pharmacy, Chungbuk National University)
Oh Ki Wan (College of Pharmacy, Chungbuk National University)
Hong Jin Tae (College of Pharmacy, Chungbuk National University)
Publication Information
Archives of Pharmacal Research / v.28, no.9, 2005 , pp. 1073-1078 More about this Journal
Abstract
A presenilin 2 mutation is believed to be involved in the development of Alzheimer's disease. In addition, transgenic mice with a presenilin 2 mutation have been reported to have learning and memory impairments. In this study, exposing PC12 cells expressing mutant presenilin 2 to $50{\mu}M\;A{\beta}_{25-35},\;30mM$ L-glutamate and $50{\mu}M\;H_2O_2$ caused a significant increase in acetylcholine esterase activity. An in vivo study revealed high levels of this enzyme activity in the mutant presenilin 2 transgenic brains compared with the wild type presenilin 2 transgenic and non-transgenic samples. These results suggest that a mutant presenilin 2-induced neurodegeneration in Alzheimer's disease might be involved in the increase in acetylcholinesterase activity. These findings might help in the development of an appropriate therapeutic intervention targeting mutant presenilin 2-induced Alzheimer's disease.
Keywords
Neuronal cell; Presenilin 2; Acetylcholine esterase; Alzheimer's disease;
Citations & Related Records

Times Cited By Web Of Science : 2  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Melo, J. B., Agostinho, P., and Oliveira, C. R., Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci. Res., 45, 117-127 (2003)   DOI   ScienceOn
2 Nguyen, H. N., Lee, S. Y., Hwang, D. Y., Kim, Y. K., Yuk, D. Y., Lee, J. S., and Hong, J. T., Decrease in NF-kappaB, AP-1 and SP-1 activities in neuronal cells expressing presenilin 2. Neuroreport, 16; 731-735 (2005)   DOI   ScienceOn
3 Shen, Z. X., Brain cholinesterase: The molecular and cellular basis of Alzheimer's disease. Med. Hypotheses, 63, 308-321 (2004)   DOI   ScienceOn
4 Tamotsu, H. G, Atsushi, T, Yoshihisa, W., Naoyuki, I., Takashi, M., and Takeshi, T, A unifying model for functional difference and redundancy of presenilin-1 and -2 in cell apoptosis and differentiation. Gene, 34257, 1-9 (2003)
5 Zhang, H. Y., Brimijoin, S., and Tang, X. C., Apoptosis induced by beta-amyloid 25-35 in acetylcholinesterase-overexpressing neuroblastoma cells. Acta Pharmacol. Sin., 24, 853-858 (2003)
6 Ellman, G. L., Courtney, K. D., Andres, V. Jr., and Featherstone, R. M., A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol., 7, 88-95 (1961)   DOI   ScienceOn
7 Saez-Valero, J., Fodero, L. R., White, A. R., Barrow, C. J., Small, D. H., Acetylcholinesterase is increased in mouse neuronal and astrocyte cultures after treatment with betaamyloid peptides. Brain Res., 965, 283-286 (2003)   DOI   PUBMED   ScienceOn
8 Alves da Costa, C., Paitel, E., Mattson, M. P., Amson, R., Telerman, A., Ancolio, K., and Checler, F., Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons. Proc. Natl. Acad. Sci. U.S.A., 99, 4043-4048 (2002)   DOI   ScienceOn
9 Deng, G., Pike, C. J., and Cotman, C. W., Alzheimer's associated presenilin2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Lett., 397, 50-54 (1996)   DOI   PUBMED   ScienceOn
10 Vito, P., Lacana, E., and D'Adamio, L., Interfering with apoptosis: Ca-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science, 271, 521-525 (1996)   DOI   PUBMED   ScienceOn
11 Mori, M., Nakagami, H., Morishita, R., Mitsuda, N., Yamamoto, K., Yoshimura, S., Ohkubo, N., Sato, N., Ogihara, T, and Kaneda, Y, N141l mutant presenilin 2 gene enhances neuronal cell' death and decrease bcl2 expression. Life Sci., 70, 2567-2580 (2002)   DOI   ScienceOn
12 Alvarez, A., Alarcon, R., Opazo, C., Campos, E. O., Munoz, F.J., Calderon, F.H., Dajas, F., Gentry, M. K., Doctor, B. P., De Mello, F. G., and Inestrosa, N. C., Stable complexes involving acetylcholinesterase and amyloid beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J. Neurosci., 18, 3213-3223(1999)
13 Inestrosa, N. C., Alvarez, A, Perez, C. A., Moreno, R. D., Vicente, M., Linker, C., Casaneuva, O. I., Soto, C., and Garrido, J., Acetylcholinesterase accelerates assembly of amyloid beta peptides into Alzheimer's fibrils: Possible role of the periferal site of the enzyme. Neuron, 16, 881-891 (1996)   DOI   ScienceOn
14 Lee, S. Y., Hwang D. Y., Kim, Y. K., Lee, J. W., Shin, I. C., Oh, K. W., Lee, M. K., Lim, J. S., Yoon, D. Y., Hwang, S. J., and Hong, J. T., PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release. FASEB J., in press (2005)
15 Rocchi, A., Pellegrini, S., Siciliano, G, and Murri, L., Causative and susceptibility genes for Alzheimer's disease. A review. Brain Res. Bull., 61, 1-24 (2003)   DOI   ScienceOn
16 Yang, L., He, H. Y., Zhang, X. J., Increased expression of intranuclear AChE involved in apoptosis of SK-N-SH cells. Neurosci. Res., 42, 261-268 (2002)   DOI   ScienceOn
17 Song, Y. S., Park, H. J., Kim, S. Y., Lee, S. H., Yoo, H. S., Lee, H. S., Lee, M. K., Oh, K. W., Kang, S. K., Lee, S. E., and Hong, J. T., Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: Reduction of NF-kappaB and p38 MAP kinase activation. Neurosci. Res., 49, 69-80 (2004)   DOI   ScienceOn
18 Vito, P., Wolozin, B., Ganjei, J. K., Iwasaki, K., Lacana, E., and D'Adamio, L., Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J. Biol. Chem., 271, 31025-31028 (1996)   DOI   ScienceOn
19 Hu, W., Gray, N. W., and Brimijoin, S., Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation. J. Neurochem., 86, 470-478 (2003)   DOI   ScienceOn
20 Kuhl, D. E., Koeppe, R. A., Minoshima, S., Snyder, S. E., Ficaro, E. P., Foster, N. L., Frey, K. A., and Kilbourn, M. R., In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology, 52, 691-699 (1999)   DOI   ScienceOn
21 Lei, Y., Heng, Y. H., and Xue, J. Z., Increase expression of intranuclear AChE involved in apoptosls of SK-N-SH cells. Neurosci. Res., 42, 261-268 (2002)   DOI   ScienceOn
22 Janicki, S. M. and Monterio, M. J., Presenilin overexpression arrests cells in the G1 phase of cell cycle. Arrest potentiated by the Alzheimer's disease PS2 (N141I) mutant. Am. J. Pathol.,155, 135-144 (1999)   DOI   ScienceOn
23 Araki, W., Yuasa, K., Takeda, S., Takeda, K., Shirotani, K., Takahashi, K., and Tabira, T., Pro apoptotic effect of presenilin 2 (PS2) overexpression is associated with down regulation of Bcl2 in cultured neurons. J. Neurochem., 79,1161-1168 (2001)   DOI   ScienceOn
24 Hwang, D. Y, Chae, K. R., Kang, T. S., Hwang, J. H., Lim, C. H., Kang, H. K., Goo, J. S., Lee, M. R., Lim, H. J., Min, S. H., Cho, J. Y, Hong, J. T., Song, C. W, Paik, S. G, Cho, J. S., and Kim, Y. K., Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. FASEB J, 16, 805-813 (2002)   DOI   ScienceOn
25 Rees, T, Hammond, P. I., Soreq, H., Younkin, S., and Brimijoin, S., Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol. Aging, 24, 777-787 (2003)   DOI   ScienceOn
26 Janicki, S. and Montaeiro, M. J., Increase apoptosis arising from increased expression of the Alzheimer's diseaseassociated presenilin 2 mutation (N141I). J. Cell Biol., 139, 485-495 (1997)   DOI   ScienceOn
27 Li, Y., Liu, L., Kang, J., Sheng, J. G., Barger, S. W., Mrak, R. E., and Griffin, W. S., Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J. Neurosci., 20, 149-155 (2000)
28 Fodero, L. R., Mok, S. S., Losic, D., Martin, L. L., Aguilar, M. I., Barrow, C. J., Livett, B. G., and Small, D. H., Alpha7-nicotinic acetylcholine receptors mediate an Abeta (1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones. J. Neurochem., 88, 1186-1193 (2004)   DOI   ScienceOn
29 Sberna, G., Saez-Valero, J., Beyreuther, K., Masters, C. L., and Small, D. H., The amyloid beta-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J. Neurochem., 69, 1177-1184 (1997)   DOI   ScienceOn